EP1461603A2 - Analysis system for determining an analyte concentration, taking into consideration sample- and analyte-independent light-intensity changes - Google Patents
Analysis system for determining an analyte concentration, taking into consideration sample- and analyte-independent light-intensity changesInfo
- Publication number
- EP1461603A2 EP1461603A2 EP02805760A EP02805760A EP1461603A2 EP 1461603 A2 EP1461603 A2 EP 1461603A2 EP 02805760 A EP02805760 A EP 02805760A EP 02805760 A EP02805760 A EP 02805760A EP 1461603 A2 EP1461603 A2 EP 1461603A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- test element
- wavelength range
- sample
- absorption
- light
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000012491 analyte Substances 0.000 title claims abstract description 64
- 238000004458 analytical method Methods 0.000 title claims abstract description 43
- 238000012360 testing method Methods 0.000 claims abstract description 155
- 238000012937 correction Methods 0.000 claims abstract description 70
- 238000005259 measurement Methods 0.000 claims abstract description 30
- 238000000034 method Methods 0.000 claims abstract description 24
- 238000010521 absorption reaction Methods 0.000 claims description 62
- 238000011156 evaluation Methods 0.000 claims description 23
- 238000001514 detection method Methods 0.000 claims description 21
- 230000001419 dependent effect Effects 0.000 claims description 9
- 239000003153 chemical reaction reagent Substances 0.000 claims description 8
- 239000000126 substance Substances 0.000 claims description 7
- 238000004364 calculation method Methods 0.000 claims description 5
- 230000031700 light absorption Effects 0.000 claims description 5
- 230000005855 radiation Effects 0.000 claims description 4
- 239000006096 absorbing agent Substances 0.000 claims description 3
- 238000005286 illumination Methods 0.000 claims description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 6
- 239000008103 glucose Substances 0.000 abstract description 6
- 239000000523 sample Substances 0.000 description 64
- 239000008280 blood Substances 0.000 description 12
- 210000004369 blood Anatomy 0.000 description 12
- 230000003287 optical effect Effects 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000011109 contamination Methods 0.000 description 4
- 230000008878 coupling Effects 0.000 description 4
- 238000010168 coupling process Methods 0.000 description 4
- 238000005859 coupling reaction Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000002250 absorbent Substances 0.000 description 2
- 230000002745 absorbent Effects 0.000 description 2
- 238000011088 calibration curve Methods 0.000 description 2
- 239000012876 carrier material Substances 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 238000000295 emission spectrum Methods 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000001678 irradiating effect Effects 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- UJMBCXLDXJUMFB-GLCFPVLVSA-K tartrazine Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1\N=N\C1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-GLCFPVLVSA-K 0.000 description 2
- 229960000943 tartrazine Drugs 0.000 description 2
- 235000012756 tartrazine Nutrition 0.000 description 2
- 239000004149 tartrazine Substances 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 230000003679 aging effect Effects 0.000 description 1
- 150000004982 aromatic amines Chemical class 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009535 clinical urine test Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000023077 detection of light stimulus Effects 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 238000002848 electrochemical method Methods 0.000 description 1
- 238000003891 environmental analysis Methods 0.000 description 1
- 238000013213 extrapolation Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000011964 heteropoly acid Substances 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- KOOMFXGDLMRWSN-UHFFFAOYSA-N n-phenylnitrous amide Chemical class O=NNC1=CC=CC=C1 KOOMFXGDLMRWSN-UHFFFAOYSA-N 0.000 description 1
- 238000005375 photometry Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/84—Systems specially adapted for particular applications
- G01N21/8483—Investigating reagent band
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/27—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands using photo-electric detection ; circuits for computing concentration
Definitions
- the present invention falls within the field of analysis of sample liquids using analyte-specific, disposable test elements.
- sensor measuring devices in which the blood glucose is determined on the basis of an electrochemical measurement
- optical systems in which an analyte-dependent color change on the test element serves to determine the analyte concentration
- test elements often represents a method for quickly determining the concentration of analytes in samples.
- test elements that are evaluated photometrically or by reflection photometry are of great importance.
- Common home monitoring analysis systems for determining the blood glucose content which are operated by the patient himself, contain test elements on which an analysis area is arranged which is brought into contact with the patient's blood.
- the test element is inserted into the device by the user.
- a suitable optical measuring system detects an optical change depending on the analyte concentration by means of the light reflected or transmitted by the test element, so that the concentration of the blood sugar can be determined.
- Such a system is described, for example, in document EP B 0 618 443.
- such devices are commercially available, for. B. available under the names Accutrend ® , Accu Check ® , Glucotrend ® and Glucometer®.
- test elements The structure of such test elements is shown for example in document US 6,036,919.
- Disruptive influences on the light intensity are such. B. caused by non-constant measuring conditions and by sample components in the analysis systems, which have an effect on the amount of light registered by a detector. Such analyte-independent changes in light intensity lead to falsified measurement results, so that, for. B. the glucose concentration is incorrectly determined.
- Detector is detected.
- fluctuations in the measurement conditions are caused by a non-constant performance of optical components, for example the lighting unit or the detector due to aging effects or contamination.
- test element contains light-conducting elements and thus forms part of the lighting unit.
- the light is coupled into the light-guiding elements of the test element, passed through and the transmitted or reflected light is coupled out again.
- Variances z. B. in the production of the test elements different connections of the test elements to the device optics or contamination, to name just a few factors, significantly influence the measurement results.
- the object of the invention is to determine non-constant instrumental measuring conditions of an analysis system which determines the analyte concentration on the basis of absorption measurements and to take this into account when correcting the measured value.
- the invention enables error correction due to non-constant measuring conditions within the analysis system.
- a preferred embodiment of the invention enables changes in sample light intensity to be detected in addition to the fluctuations in apparatus measuring conditions.
- the invention consequently allows a more precise calculation of analyte concentrations due to light absorption by the analyte, whereby a change in analyte-independent measurement conditions is taken into account.
- the analysis system includes a test element that has an absorption of light in a first wavelength range that is known and not equal to zero before sample application, an illumination unit that emits at least two different wavelength ranges and irradiates the test element, a detector unit that is positioned in this way, that transmitted or reflected light of the test element is registered and an evaluation unit with which a correction value is determined from an analyte-independent absorption of the test element in the first wavelength range and with which a measured value is determined in a second wavelength range from an analyte-dependent absorption of the test element.
- the concentration of the analyte is determined by means of the evaluation unit with a correction of the measured value taking into account the correction value.
- Lighting units in the sense of the invention are both those with an essentially continuous emission spectrum, such as. B. incandescent lamps, as well as those that have a so-called band spectrum, such as. B. LEDs.
- Light emitting diodes are particularly well suited for use in a portable analysis system because they have a relatively high degree of efficiency, which is important for battery-operated devices.
- LEDs are available for a number of wavelength ranges in the visible as well as in the infrared range. In principle, the light sources known in the prior art for diagnostic detection systems are suitable. Wavelength ranges that can be used in the context of the invention include UV and IR in addition to the visual range.
- Test elements in the sense of the invention are used for sample application, so that an analyte in the sample can be determined by the analysis system, the test element being designed in such a way that it has an absorption in a first wavelength range that is known and not equal to zero.
- test elements are designed in the form of strips in the sense of the invention.
- An absorbent carrier material is preferably applied to a holder which is used for handling.
- the test field there is, for example, a reagent layer that reacts with the analyte. The sample brought into contact with the detection zone leads to a detectable change in the test field in the test element.
- the analyte reacts with the reagent layer, which consists, for example, of a heteropolyacid and which is reduced by the analyte to the dye heteropoly blue.
- the formation of the dye takes place depending on the analyte concentration and is considered a change in the Test field detected in the visible range of the spectrum.
- the analyte is an electron-rich aromatic amine or is reacted with a substance to this.
- a substance can be a nitrosoaniline derivative which, in a preferred embodiment, has a previously known absorption in the first wavelength range.
- test element is subject, among other things, to certain manufacturing tolerances, so that measurement errors are thereby caused.
- test elements can include a light-conducting layer, in which total reflection preferably takes place.
- the light is coupled in through an input surface, which is preferably formed by a cut surface on the front face of the light guide layer.
- the refractive index of the light guide layer in the area of the detection zone can be changed so that total reflection no longer takes place. It is also possible to effect the coupling out of the light by means of a suitable light guide within the light guide layer. Possible embodiments of light-guiding test elements are shown in patent application WO 01/48461.
- the fluctuations in the measurement conditions caused by light-conducting test elements are detected by the analysis system according to the invention, so that a correction according to the invention is obtained when light-conducting test elements are used proves to be particularly cheap.
- detectors in particular semiconductor detectors
- Detectors that have their maximum sensitivity in the range of the reflected or transmitted radiation can advantageously be used.
- filters can also be used which selectively let the measuring radiation pass through in order to make the detection more stable against the effects of stray light.
- filters are particularly necessary when using lighting units with a continuous emission spectrum.
- the filters can be requested both from the lighting unit and from the detector in order to achieve a selection of desired wavelengths.
- the evaluation unit of the analysis system contains a module for error correction, which can be implemented, for example, with an operational amplifier.
- the evaluation unit registers the counts generated depending on the light intensity in the detector as a measure of a relative light intensity. By referencing the registered counts to a reference, e.g. B. the white value, whose registered counts are set equal to 100% of the light intensity, the evaluation unit calculates an absolute light intensity and the correction of this light intensity as described.
- the concentration can be determined on the basis of the light intensity.
- the use of calibration curves for determining the concentration is e.g. B. described in document EP 0 247439.
- the analysis system preferably contains an evaluation unit which additionally determines the light intensity detected by the detector in the second or in a third wavelength range, with essentially no absorption by the test element taking place in this wavelength range.
- the absorption values in a third wavelength range or in the second wavelength range, in which there is essentially no absorption in the wavelength range, are referred to as white values. If this white value is measured in a preferred manner in the second, same wavelength range as the analyte, the measurement is carried out on the test element before the sample is added. Consequently, no further optics for a wavelength range have to be provided for the determination of the white value.
- the evaluation unit calculates the measured value taking into account the white value, so that in addition to the detection of the correction value, an additional error correction takes place.
- the correction value of the analysis system which is measured in the first length range, can be e.g. B. can be determined on the basis of a dry test element which in the first wavelength range advantageously absorbs more than 50%, better more than 80%, particularly completely (approximately 100%) the light. Complete absorption of the dry test element proves to be advantageous, since error minimization therefore takes place for further calculation steps.
- the evaluation unit can thus detect or calculate the amount of light in this wavelength range, which is registered by the detector despite 100% light absorption of the test element. This measured value is referred to as the black value, since the idealized
- Behavior of the measuring apparatus no light would be detected. This means that the amount of light is registered in real behavior, which is not absorbed a priori by the test element and whose change z. B. is influenced by contamination of the test element, ambient light, quality differences in test elements, etc.
- the known absorption in the first length range is by an absorber present in the test element, such as. B. tartrazine, which does not interact with the sample, so that, for. B. Even after sample application, a known absorption is guaranteed.
- the test elements used advantageously have a light-conducting element and are coupled to a lighting unit, so that they represent part of the lighting unit.
- the correction value can also be measured on a wet test element after sample application. Under these conditions, the amount of light is recorded, which is registered by the detector in the case of previously known absorption of the test element and additionally sample-dependent absorption in the first wavelength range. A correction of the measured value by this correction value consequently takes into account the analyte-independent influence of the sample in the first wavelength range (e.g. sample's own color, change in the refractive index due to wetting) in addition to the change in apparatus measurement conditions.
- the analyte-independent influence of the sample in the first wavelength range e.g. sample's own color, change in the refractive index due to wetting
- the evaluation unit registers at least two correction values, the absorption of the dry test element before sample addition and the absorption of the wet test element after sample addition being recorded in the first wavelength range.
- the proportion of absorption in the first wavelength range is determined, which is sample-dependent and analyte-independent and is not influenced by measuring conditions.
- the sample-related change in light intensity in the first wavelength range is used to infer the sample-related change in light intensity in the second wavelength range.
- z. B. the sample-related change in light intensity in the first length range is set essentially equal to the change in sample intensity in the second length range.
- B. can be determined by extrapolation to the sample-related change in light intensity in the second wavelength range.
- the prior art measures in a first wavelength range in which the test element does not absorb or does not absorb significantly, so that a white value of the system is consequently determined.
- measurements in a first wavelength range determine the influence of the sample on the analysis result, since during the measurement an additional absorption is caused by blood dye in the sample.
- the white length range is extrapolated to the absorption of the blood pigment in the second white length range (EP-A3-0 816849).
- a black value as defined above is not taken into account in the corrections mentioned. Within the scope of the invention, however, it is possible to take into account a correction for the white value and / or the influence of the sample, as described, when correcting the measured values by the black value.
- the invention additionally relates to two methods for the detection of light intensity changes in analysis systems which are not due to analysis.
- a method includes irradiating a test element before adding the sample and detecting the light reflected or transmitted by the test element in a first wavelength range in which absorption by the dry test element takes place, which is known and not equal to zero. This absorption becomes a first Correction value determined. Subsequently, the test element is irradiated after adding the sample and detecting the light reflected or transmitted by the test element in the first wavelength range in which an analyte-independent absorption by the wet test element takes place. A second correction value is registered by means of this change in light intensity.
- the wet test element is irradiated and the light reflected or transmitted by the test element is detected in a second wavelength range in which absorption by an analyte takes place. The measurement value is thus detected.
- the first correction value is used to determine the amount of light which is registered by the detector despite essentially complete absorption of the test element. If the dry test element has essentially complete absorption in the first wavelength range, the detected correction value corresponds to the black value of the system. In the case of a previously known but essentially incomplete absorption of the dry test element, the black value is calculated using the evaluation unit.
- the second correction value represents the sum of the changes in light intensity due to the previously known absorption of the dry test element and the sample-related, analyte-independent absorption. On the basis of a differential curve from the correction values, the sample-related amount of changes in light intensity is separated from the portion due to the equipment. The analyte concentration is then determined in the second wavelength range with a correction of the measured value taking into account the black value and the sample-related absorption.
- a further method for analyzing and correcting changes in light intensity not caused by the analysis is carried out by irradiating a test element before or after adding a sample and detecting the light reflected or transmitted by the test element in a first wavelength range in which absorption takes place either by the dry test element, which is previously known and not equal to zero and is used to determine a first correction value or the absorption by the wet test element is determined to determine a second correction value.
- the first correction value is used to determine the black value.
- the second correction value additionally includes changes in light intensity that arise as a result of a sample influence.
- the test element is irradiated and the light reflected or transmitted by the test element is detected in a second wavelength range in which absorption by an analyte takes place to determine the measured value.
- the analyte concentration is determined by correcting the measured value, taking into account the first or second correction value, so that either only the black value of the method is taken into account or, in addition, the influence of the sample.
- test elements with the particular light-conducting properties shown can be used.
- the determination of a correction value in the first range of lengths is sufficient, so that the latter method is to be preferred for correcting the measured value. If this is not the case, the sample-related absorption in the first wavelength range can preferably be determined in a further method step in accordance with the first-mentioned method and used to determine the sample-related absorption in the second wavelength range.
- (I I ⁇ O / 0 ) is a theoretically expected light intensity, which results from the light emitted by the lighting unit with ideal behavior of the analysis system.
- the real detected light intensity (Iv teß ) includes a change in light intensity ( ⁇ App (i)) - which results from non-constant equipment conditions (e.g. intensity fluctuations due to ambient light, changing quality of the test strips; faulty coupling of the test strip to the lighting unit by the User; equation 2).
- I APP can be both positive and negative.
- the first correction value captures the light intensity, which is independent of the analyte and sample and cannot be absorbed a priori by the test element.
- the measured value (I mess) is equal to the correction value (i app (i)) is the measured value (I mess) is called black level.
- the black value thus reflects the minimum light intensity that is registered by the detector despite the almost complete absorption of the test element.
- the correction value (IA PP ( 2 )) includes not only changes in light intensity due to equipment, but also light intensity changes caused by the analyte-independent influence of the sample caused (e.g. absorption by sample components, change in the refractive index on the test element). If a correction value is measured exclusively on the wet test element, the measurement value (lAnalyt) is also corrected when determining an analyte concentration by subtraction analogous to equation 3.
- a first correction value is preferably determined before determining the second correction value before sample application. By forming the difference between the correction values, only the sample-related changes in light intensity in the first wavelength range can be recorded.
- a comprehensive correction of the measured value can also take a white value into account when determining an analyte concentration.
- the white value is determined in a white length range in which the test element essentially does not absorb. The white value thus reflects the maximum light intensity that is detected by the detector.
- the first correction value is first determined in the first length range. This is followed by a measurement in the second wavelength range, in which there is almost no absorption by the test element, so that the white value is registered.
- the sample is placed on the test field, a reaction of the analyte to be determined being initiated with a reagent. After the end of the reaction, measurements are again carried out in the second wavelength range, with the analyte-dependent absorption now being detected.
- the first correction value corresponds to a black value, which is independent of the sample and analyte;
- the second correction value is a black value, which is independent of the analyte.
- the difference in the black values results in the sample-related change in light intensity (Ip ro be) in the first wavelength range. From the sample-related change in light intensity in the first Wavelength range is based on the sample-related change in light intensity in the second wavelength range (Lprobe) -
- a correction value (I ⁇ 0 correction ) is determined according to equation 4.
- the invention further includes a test element with light-guiding properties for the application and analysis of samples.
- the test element contains an absorber, e.g. B. tartrazine, which has a known non-zero absorption in a first wavelength range in which there is essentially no absorption due to an analyte, which absorption is essentially complete in a preferred embodiment. There are no interactions between the substance and the sample.
- the test element contains a reagent system which reacts with the analyte of the sample in such a way that an analyte-dependent change in the absorption takes place in a second wavelength range.
- the substance absorbs in the blue white length range.
- Figure 2 Structure of an analysis system with light-conducting test element according to patent application WO 01/48464
- Figure 3 Structure of a light-conducting test element according to patent application WO 01/48464
- the analysis system 1 shown in FIGS. 1 and 2 contains a test element (2) and an evaluation device (3).
- the test element (2) is designed as a test strip (4) with an elongated carrier film (5) made of plastic and a test field (7) attached to the upper flat side (6) of the carrier film (5).
- the test element (2) is inserted through an opening (10) into the housing (11) of the evaluation device (3) into a test element holder (12) and thereby positioned in the measuring position shown in FIG. 2.
- the evaluation device (3) contains measurement and evaluation electronics 13, which in the case shown is implemented by means of a printed circuit board (14) and integrated circuits 15.
- a light transmitter (16) preferably implemented as a light-emitting diode (LED)
- a detector 17 preferably implemented as a photodiode, which are components of an optical measuring device (18).
- a drop of sample liquid (21) is applied to the side (top) of the test field (7) facing away from the carrier film (5).
- the application of the sample is facilitated by the fact that only a first section (22) of the test element (2) positioned in the measuring position is inside the housing (11), while a second section (23) with the test field (7) is out of the housing (11) protrudes and is therefore easily accessible.
- the liquid penetrates, dissolving the reagents contained in the test field (7), until it reaches the detection zone (24), which is located on the side (underside) of the test field (7) facing the carrier film (5).
- the reaction of the analyte contained in the sample with the reagent system leads to an optically measurable change, in particular a color change, in the detection zone (24).
- an optically measurable change in particular a color change
- the secondary light intensity which is diffusely reflected when the detection zone (24) is illuminated with primary light is measured. This is done by a special design of the test element (2) and the interacting parts of the optical measuring device (18).
- Figure 3 shows a test element with light-conducting elements.
- the carrier film (5) includes at least one optical light guide layer (26) with the properties explained with regard to optical transparency and refractive index. Further information on light guide elements whose light transport is based on total reflection can be found in the relevant literature (WO 01/48461).
- the carrier film (5) has two light guide layers (26), the upper light guide layer serving as a primary light guide (27) and the lower light guide layer serving as a secondary light guide (28).
- the primary light (29) is coupled by the light transmitter (16) with the aid of a lens (30) into the primary light guide (27) through its rear end face, which serves as the input surface (31) for the coupling, and within the primary light guide (27) up to the test field (7) transported.
- the part of the light path of the primary light (29) which runs inside the light guide layer (26) is referred to as the light guide section (32).
- the area of the upper flat side (6) of the light guide layer (26) which is aligned with the test field serves at least in part as a light decoupling area (33) in which the primary light (29) from the primary light guide (27) into the detection zone (24) of the Test field (7) is coupled out.
- the primary light (29) is essentially decoupled by the fact that the lower flat side of the carrier film (5) opposite the decoupling region (33) (also also the test field (7)) (in the two-layer embodiment of the carrier film shown, the lower flat side of the primary light guide (27)) is designed such that the primary light is deflected into the detection zone (24) of the test field (7).
- This change in the direction of light propagation is brought about by a reflecting surface (25) which is preferably inclined at an angle of approximately 45 °. They should be polished and / or provided with a shiny metallic coating to improve their reflective properties. Deviations from the angle of 45 ° are possible.
Abstract
Description
Claims
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10163775 | 2001-12-22 | ||
DE10163775A DE10163775A1 (en) | 2001-12-22 | 2001-12-22 | Analysis system for determining an analyte concentration taking into account sample and analyte-independent changes in light intensity |
PCT/EP2002/014534 WO2003056314A2 (en) | 2001-12-22 | 2002-12-19 | Analysis system for determining an analyte concentration, taking into consideration sample- and analyte-independent light-intensity changes |
Publications (1)
Publication Number | Publication Date |
---|---|
EP1461603A2 true EP1461603A2 (en) | 2004-09-29 |
Family
ID=7710735
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP02805760A Withdrawn EP1461603A2 (en) | 2001-12-22 | 2002-12-19 | Analysis system for determining an analyte concentration, taking into consideration sample- and analyte-independent light-intensity changes |
Country Status (7)
Country | Link |
---|---|
US (1) | US7758812B2 (en) |
EP (1) | EP1461603A2 (en) |
JP (1) | JP2005513498A (en) |
AU (1) | AU2002367206A1 (en) |
CA (1) | CA2470862A1 (en) |
DE (1) | DE10163775A1 (en) |
WO (1) | WO2003056314A2 (en) |
Families Citing this family (72)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6036924A (en) | 1997-12-04 | 2000-03-14 | Hewlett-Packard Company | Cassette of lancet cartridges for sampling blood |
US6391005B1 (en) | 1998-03-30 | 2002-05-21 | Agilent Technologies, Inc. | Apparatus and method for penetration with shaft having a sensor for sensing penetration depth |
US8641644B2 (en) | 2000-11-21 | 2014-02-04 | Sanofi-Aventis Deutschland Gmbh | Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means |
US9795747B2 (en) | 2010-06-02 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
US9427532B2 (en) | 2001-06-12 | 2016-08-30 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7025774B2 (en) | 2001-06-12 | 2006-04-11 | Pelikan Technologies, Inc. | Tissue penetration device |
US8337419B2 (en) | 2002-04-19 | 2012-12-25 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7981056B2 (en) | 2002-04-19 | 2011-07-19 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
US9226699B2 (en) | 2002-04-19 | 2016-01-05 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling module with a continuous compression tissue interface surface |
US7682318B2 (en) | 2001-06-12 | 2010-03-23 | Pelikan Technologies, Inc. | Blood sampling apparatus and method |
EP1404233B1 (en) | 2001-06-12 | 2009-12-02 | Pelikan Technologies Inc. | Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties |
ATE497731T1 (en) | 2001-06-12 | 2011-02-15 | Pelikan Technologies Inc | DEVICE FOR INCREASING THE SUCCESS RATE OF BLOOD YIELD OBTAINED BY A FINGER PICK |
EP1404235A4 (en) | 2001-06-12 | 2008-08-20 | Pelikan Technologies Inc | Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge |
JP4149911B2 (en) | 2001-06-12 | 2008-09-17 | ペリカン テクノロジーズ インコーポレイテッド | Electric lancet actuator |
US7909778B2 (en) | 2002-04-19 | 2011-03-22 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7232451B2 (en) | 2002-04-19 | 2007-06-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8784335B2 (en) | 2002-04-19 | 2014-07-22 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling device with a capacitive sensor |
US8267870B2 (en) | 2002-04-19 | 2012-09-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling with hybrid actuation |
US7229458B2 (en) | 2002-04-19 | 2007-06-12 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7291117B2 (en) | 2002-04-19 | 2007-11-06 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7901362B2 (en) | 2002-04-19 | 2011-03-08 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7648468B2 (en) | 2002-04-19 | 2010-01-19 | Pelikon Technologies, Inc. | Method and apparatus for penetrating tissue |
US7892183B2 (en) | 2002-04-19 | 2011-02-22 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
US7175642B2 (en) | 2002-04-19 | 2007-02-13 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
US8702624B2 (en) | 2006-09-29 | 2014-04-22 | Sanofi-Aventis Deutschland Gmbh | Analyte measurement device with a single shot actuator |
US7491178B2 (en) | 2002-04-19 | 2009-02-17 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US9314194B2 (en) | 2002-04-19 | 2016-04-19 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7717863B2 (en) | 2002-04-19 | 2010-05-18 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US9248267B2 (en) | 2002-04-19 | 2016-02-02 | Sanofi-Aventis Deustchland Gmbh | Tissue penetration device |
US7976476B2 (en) | 2002-04-19 | 2011-07-12 | Pelikan Technologies, Inc. | Device and method for variable speed lancet |
US7331931B2 (en) | 2002-04-19 | 2008-02-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7297122B2 (en) | 2002-04-19 | 2007-11-20 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7226461B2 (en) | 2002-04-19 | 2007-06-05 | Pelikan Technologies, Inc. | Method and apparatus for a multi-use body fluid sampling device with sterility barrier release |
US8221334B2 (en) | 2002-04-19 | 2012-07-17 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7547287B2 (en) | 2002-04-19 | 2009-06-16 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7674232B2 (en) | 2002-04-19 | 2010-03-09 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US9795334B2 (en) | 2002-04-19 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7371247B2 (en) | 2002-04-19 | 2008-05-13 | Pelikan Technologies, Inc | Method and apparatus for penetrating tissue |
US8579831B2 (en) | 2002-04-19 | 2013-11-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
AU2003296703A1 (en) * | 2002-12-23 | 2004-07-14 | F.Hoffmann-La Roche Ag | Transport device for transporting test strips in an analysis system |
US8574895B2 (en) | 2002-12-30 | 2013-11-05 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus using optical techniques to measure analyte levels |
US7850621B2 (en) | 2003-06-06 | 2010-12-14 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
WO2006001797A1 (en) | 2004-06-14 | 2006-01-05 | Pelikan Technologies, Inc. | Low pain penetrating |
EP1671096A4 (en) | 2003-09-29 | 2009-09-16 | Pelikan Technologies Inc | Method and apparatus for an improved sample capture device |
EP1671110A1 (en) | 2003-10-03 | 2006-06-21 | Bayer HealthCare LLC | Precision correction of reflectance measurements |
WO2005037095A1 (en) | 2003-10-14 | 2005-04-28 | Pelikan Technologies, Inc. | Method and apparatus for a variable user interface |
US7822454B1 (en) | 2005-01-03 | 2010-10-26 | Pelikan Technologies, Inc. | Fluid sampling device with improved analyte detecting member configuration |
US8668656B2 (en) | 2003-12-31 | 2014-03-11 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for improving fluidic flow and sample capture |
EP1751546A2 (en) | 2004-05-20 | 2007-02-14 | Albatros Technologies GmbH & Co. KG | Printable hydrogel for biosensors |
US20050276133A1 (en) * | 2004-05-30 | 2005-12-15 | Agamatrix, Inc. | Measuring device and methods for use therewith |
US7964146B2 (en) | 2004-05-30 | 2011-06-21 | Agamatrix, Inc. | Measuring device and methods for use therewith |
WO2005120365A1 (en) | 2004-06-03 | 2005-12-22 | Pelikan Technologies, Inc. | Method and apparatus for a fluid sampling device |
US8652831B2 (en) | 2004-12-30 | 2014-02-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte measurement test time |
US20070103678A1 (en) * | 2005-02-14 | 2007-05-10 | Sterling Bernhard B | Analyte detection system with interferent identification and correction |
US8251907B2 (en) | 2005-02-14 | 2012-08-28 | Optiscan Biomedical Corporation | System and method for determining a treatment dose for a patient |
US8597190B2 (en) | 2007-05-18 | 2013-12-03 | Optiscan Biomedical Corporation | Monitoring systems and methods with fast initialization |
WO2009126900A1 (en) | 2008-04-11 | 2009-10-15 | Pelikan Technologies, Inc. | Method and apparatus for analyte detecting device |
US9375169B2 (en) | 2009-01-30 | 2016-06-28 | Sanofi-Aventis Deutschland Gmbh | Cam drive for managing disposable penetrating member actions with a single motor and motor and control system |
CN102348808A (en) * | 2009-03-20 | 2012-02-08 | 霍夫曼-拉罗奇有限公司 | Test element for determining a body fluid and measurement method |
EP2306178A1 (en) * | 2009-09-30 | 2011-04-06 | Roche Diagnostics GmbH | Method for controlling a photometric measuring unit of a measuring device for generating and examining a body liquid sample and measuring system |
EP2325624A1 (en) * | 2009-11-18 | 2011-05-25 | F. Hoffmann-La Roche AG | Method and device for inspecting a bodily fluid |
US8965476B2 (en) | 2010-04-16 | 2015-02-24 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
WO2011156522A1 (en) | 2010-06-09 | 2011-12-15 | Optiscan Biomedical Corporation | Measuring analytes in a fluid sample drawn from a patient |
WO2013185313A1 (en) * | 2012-06-14 | 2013-12-19 | 天津天合众生医疗科技有限公司 | Detection device and method |
KR101701072B1 (en) * | 2012-09-05 | 2017-01-31 | 에프. 호프만-라 로슈 아게 | Method and device for determining sample application |
US9404794B2 (en) | 2013-02-28 | 2016-08-02 | Lifescan Scotland Limited | Ambient light compensation circuit for analyte measurement systems |
JP6379385B2 (en) * | 2014-09-20 | 2018-08-29 | テラメックス株式会社 | Test unit and sample analyzer |
WO2017136187A2 (en) * | 2016-02-01 | 2017-08-10 | Micro Detect, Inc. | Uv solid state detection and methods therefor |
US10132958B2 (en) * | 2016-07-14 | 2018-11-20 | Schlumberger Technology Corporation | Determining an optical density linear dynamic range for an optical spectrometer |
DE102018208049A1 (en) * | 2018-05-23 | 2019-11-28 | Robert Bosch Gmbh | Framework structure for interaction with an image evaluation device for at least one at least one optochemical detection surface having carrier |
EP3591385A1 (en) * | 2018-07-06 | 2020-01-08 | Roche Diabetes Care GmbH | A detection method for detecting an analyte in a sample |
DE102020115216A1 (en) * | 2019-06-07 | 2020-12-10 | IME-DC GmbH International Medical Equipment - Diabetes Care | Medical device, its use and its use |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS591977B2 (en) | 1978-01-25 | 1984-01-14 | 株式会社京都第一科学 | Analysis method using color test paper |
US4238565A (en) | 1978-06-22 | 1980-12-09 | Miles Laboratories, Inc. | Specific binding assay with a prosthetic group as a label component |
AT367796B (en) | 1979-10-29 | 1982-07-26 | List Hans | METHOD FOR DETERMINING A SUBSTANCE CONCENTRATION IN A SOLUTION |
GB8608435D0 (en) | 1986-04-07 | 1986-05-14 | Cranfield Inst Of Tech | Specific binding assays |
DE3617161A1 (en) | 1986-05-22 | 1987-11-26 | Boehringer Mannheim Gmbh | SYSTEM FOR DETERMINING THE CONCENTRATION OF INGREDIENTS OF BODY LIQUIDS |
US4935346A (en) * | 1986-08-13 | 1990-06-19 | Lifescan, Inc. | Minimum procedure system for the determination of analytes |
DE3940010A1 (en) | 1989-12-02 | 1991-06-06 | Boehringer Mannheim Gmbh | USE OF A SLOWLY SOLUBLE SALT OF A HETEROPOLYSIC ACID TO DETERMINE AN ANALYT, CORRESPONDING DETERMINATION METHOD AND APPROPRIATE MEANS |
GB9022304D0 (en) | 1990-10-15 | 1990-11-28 | Ares Serono Res & Dev Ltd | Assay technique |
DE4128846C2 (en) | 1991-08-30 | 1994-07-14 | Rainer Dr Klein | Integrated optical fabric sensor |
DE4310583A1 (en) | 1993-03-31 | 1994-10-06 | Boehringer Mannheim Gmbh | Test strip analysis system |
AU7170994A (en) * | 1993-06-08 | 1995-01-03 | Chronomed, Inc. | Two-phase optical assay method and apparatus |
JP3212779B2 (en) * | 1993-11-12 | 2001-09-25 | 富士写真フイルム株式会社 | Method for compensating for differences in the spectrometer of an optical analyzer |
JP2992738B2 (en) | 1994-07-08 | 1999-12-20 | 日本フルハーフ株式会社 | Floor structure of vehicle carrier |
MX9701792A (en) | 1994-09-08 | 1997-06-28 | Johnson & Johnson | Optically readable strip for analyte detection having on-strip standard. |
EP0711992B1 (en) * | 1994-11-08 | 2003-03-26 | Tosoh Corporation | Method of determination of a fluorescent substance, and a method of assay of an enzyme activity |
US5728352A (en) | 1994-11-14 | 1998-03-17 | Advanced Care Products | Disposable electronic diagnostic instrument |
DE19629656A1 (en) | 1996-07-23 | 1998-01-29 | Boehringer Mannheim Gmbh | Diagnostic test carrier with multilayer test field and method for the determination of analyte with its aid |
DE59908127D1 (en) | 1999-12-23 | 2004-01-29 | Opdix Optoelectronic Gmbh Bera | Detection of irregularities in the thickness of a flexible material web |
MXPA02006170A (en) * | 1999-12-24 | 2003-01-28 | Roche Diagnostics Gmbh | Test element analysis system. |
-
2001
- 2001-12-22 DE DE10163775A patent/DE10163775A1/en not_active Ceased
-
2002
- 2002-12-19 EP EP02805760A patent/EP1461603A2/en not_active Withdrawn
- 2002-12-19 JP JP2003556789A patent/JP2005513498A/en active Pending
- 2002-12-19 US US10/499,252 patent/US7758812B2/en active Active
- 2002-12-19 WO PCT/EP2002/014534 patent/WO2003056314A2/en active Application Filing
- 2002-12-19 AU AU2002367206A patent/AU2002367206A1/en not_active Abandoned
- 2002-12-19 CA CA002470862A patent/CA2470862A1/en not_active Abandoned
Non-Patent Citations (2)
Title |
---|
None * |
See also references of WO03056314A3 * |
Also Published As
Publication number | Publication date |
---|---|
DE10163775A1 (en) | 2003-07-03 |
CA2470862A1 (en) | 2003-07-10 |
AU2002367206A8 (en) | 2003-07-15 |
US7758812B2 (en) | 2010-07-20 |
WO2003056314A3 (en) | 2003-12-18 |
US20050054082A1 (en) | 2005-03-10 |
WO2003056314A2 (en) | 2003-07-10 |
JP2005513498A (en) | 2005-05-12 |
AU2002367206A1 (en) | 2003-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1461603A2 (en) | Analysis system for determining an analyte concentration, taking into consideration sample- and analyte-independent light-intensity changes | |
EP2221608B1 (en) | Test method for examining a bodily fluid | |
EP1240503B1 (en) | Test strip analysis system, medical test strip, and method of analysing a sample by the help of a test strip analysis system | |
EP1117989B1 (en) | Method for the photometric analysis of test elements | |
EP1238274B1 (en) | Test element analysis system with infrared detector | |
DE102004027132B4 (en) | Early determination of assay results | |
EP1843148B1 (en) | Analysis of optical data using histograms | |
EP0819943A2 (en) | Analysing system with means for detecting insufficient dose | |
EP1213579B1 (en) | System for the liquid sample analysis comprising a position control unit | |
EP1921441B1 (en) | Method for analysing a sample on a test element and analysis system | |
DE19958930A1 (en) | Optic alignment and calibration system | |
EP3051272A2 (en) | Method for assaying lipids and other interferents in body fluid samples | |
DE102004027130B4 (en) | Flow sampling for determination of assay results | |
EP1411346B1 (en) | Method for detection and compensation of the underdosage of test strips | |
EP2607492A1 (en) | Method for determining the concentration of an analyte | |
EP1843147A1 (en) | Spatially resolved analysis of optical data of a test element | |
EP1061371B1 (en) | Method and device for controlling the liquid absorption of an analysing element test layer | |
EP3591378B1 (en) | Method for assaying lipids, haemoglobin and bilirubin in body fluid samples | |
EP2502054B1 (en) | Method and device for inspecting a bodily fluid | |
EP2270516A2 (en) | Analysing system with means for detecting insufficient dose | |
DE19630160A1 (en) | Optical system evaluating quality of fluid distribution onto test piece, e.g. medical test strip | |
EP2825868B1 (en) | Test system and method for controlling the alignment of a test strip |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20040722 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK RO |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: F. HOFFMANN-LA ROCHE AG Owner name: ROCHE DIABETES CARE GMBH |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R079 Free format text: PREVIOUS MAIN CLASS: G01N0021860000 Ipc: G01N0021270000 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: G01N 33/487 20060101ALI20230330BHEP Ipc: G01N 21/84 20060101ALI20230330BHEP Ipc: G01N 21/27 20060101AFI20230330BHEP |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTG | Intention to grant announced |
Effective date: 20230511 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20230922 |